hematological indications

Related by string. * Hematological : hematological cancers notably . hematological malignancies . non hematological toxicities . hematological parameters . hematological toxicities . hematological malignancy / INDICATIONS . Indications . INDICATION . Indication : oncology indications . indications intermediates . clearest indication yet . contra indications . ophthalmic indications * *

Related by context. Frequent words. (Click for all words.) 66 PEG SN# 66 multi kinase inhibitor 65 deforolimus 65 ATL# [001] 64 ovarian breast 63 CCX# 63 Vandetanib 62 EGFR inhibitors 62 squalamine 62 Panzem R 62 Azedra 61 liposomal formulation 61 multiple sclerosis rheumatoid arthritis 61 cancer immunotherapies 61 preclinical compounds 61 CR# vcMMAE 61 Carfilzomib 61 CD# antibody [001] 61 hematological cancers 61 angiogenesis inhibitor 61 investigational compounds 60 ganetespib 60 CA4P 60 RGB # 60 fibrotic diseases 60 BZL# 60 Mipomersen 60 anticancer compound 60 EndoTAG TM -1 60 FGFR 60 Icatibant 59 anti fibrotic 59 Urocidin 59 BEMA TM Fentanyl 59 Octreotide 59 hematologic cancers 59 anticancer therapy 59 atacicept 59 IMC A# 59 MEK inhibitor 59 PDGFR 59 ACZ# 59 talactoferrin 59 retinal disorders 59 Epratuzumab 59 MNTX 59 luteinizing hormone releasing 59 therapeutic monoclonal antibodies 59 Aurora kinase 59 inflammation autoimmune diseases 58 PXD# 58 antiangiogenic 58 BiTE antibody 58 EGFr 58 oncolytic viruses 58 tumor antigen 58 PARP inhibitors 58 secondary hyperparathyroidism 58 R sorafenib tablets 58 custirsen 58 #ME# 58 immunologic diseases 58 otelixizumab 58 elotuzumab 58 TREANDA 58 tumor vasculature 58 Cloretazine R VNP#M 58 peptide therapeutics 58 Amrubicin 58 Dasatinib 58 Vascular Endothelial Growth 58 pharmacologic agents 58 Diamyd ® 58 axitinib 58 AP# [003] 58 RNAi therapeutic 58 GLPG# 58 Onalta 58 DDP# 58 autoimmune inflammatory 58 BAY #-# 58 Wnt signaling pathway 57 Nexavar ® 57 VALSTAR 57 tyrosine kinase inhibitor 57 FLT3 57 pertuzumab 57 novel anticancer 57 SUTENT 57 ProLindac 57 Virulizin R 57 ICA # 57 ridaforolimus 57 PEGylated 57 hematological malignancies 57 MOZOBIL 57 immuno inflammatory diseases 57 Sym# 57 ponatinib 57 oncology therapeutics 57 tanespimycin

Back to home page